(Q60462196)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Amalia Gastaldelli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Berria R

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Glass L

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Mahankali A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Miyazaki Y

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

De Filippis E

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Cusi K

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Cersosimo E

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Defronzo RA

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

14 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

275-281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

A review of rosiglitazone in type 2 diabetes mellitus

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Considerations for management of fluid dynamic issues associated with thiazolidinediones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

New aspects of the insulin resistance syndrome: impact on haematological parameters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Reciprocal association between insulin sensitivity and the haematocrit in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

A pilot clinical trial of a new oral hypoglycemic agent, CS-045, in patients with non-insulin dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Human hydrometry: comparison of multifrequency bioelectrical impedance with 2H2O and bromine dilution.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Alterations in body fluid content can be detected by bioelectrical impedance analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Deuterium dilution as a method for determining total body water: effect of test protocol and sampling time.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Effects of pioglitazone versus glipizide on body fat distribution, body water content, and hemodynamics in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Measurement of energy expenditure in humans by doubly labeled water method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Influence of delayed isotopic equilibration in urine on the accuracy of the (2)H(2)(18)O method in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Deuterium dilution: the time course of 2H enrichment in saliva, urine, and serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

The measurement of total body water in the human subject by deuterium oxide dilution; with a consideration of the dynamics of deuterium distribution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Hydration of fat-free body mass: review and critique of a classic body-composition constant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

A review of body composition studies with emphasis on total body water and fat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

1 reference

7 January 2021

Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Pivotal role of peroxisome proliferator-activated receptor gamma (PPARgamma) in regulation of erythroid progenitor cell proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Peroxisome proliferator-activated receptor gamma-mediated NF-kappa B activation and apoptosis in pre-B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Thiazolidinediones and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Thiazolidinediones: Pleiotropic drugs with potent anti-inflammatory properties for tissue protection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Platelets in inflammation and atherogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Insulin-like growth factors and insulin stimulate erythropoietin production in primary cultured astrocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Differentiating members of the thiazolidinedione class: a focus on safety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Thiazolidinedione-induced edema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Relationship between total body water and surface area in normal and obese subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100146

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361126%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference